Status:

TERMINATED

EXOme Rare Cancers in Children (EXOCARE)

Lead Sponsor:

University Hospital, Angers

Conditions:

Predisposition, Genetic

Cancer Childhood

Eligibility:

All Genders

Phase:

NA

Brief Summary

Other than high-dose radiation and previous chemotherapy, few strong risk factors have been identified as causes of childhood cancer. Geneticists estimate that 5 to 10% of all cancers diagnosed during...

Detailed Description

-Primary objective : Our aim is to identify new mutations and genes involved in paediatric cancer predisposition associating developmental delay by WES of a sub-cohort of patients included in the TED ...

Eligibility Criteria

Inclusion

  • For "Patient cancer" :
  • Child having developed a cancer combined with a delay of development and\\or an intellectual deficiency before the age of 18 years and followed for a cancer of the child in one of hospital center of the Société Française de lutte contre les Cancers et les leucémies de l'Enfant et de l'adolescent (SFCE)
  • At least a parent still alive and available to make genetic analyses
  • For "Parent of cancer patient" :
  • Parent whose child meets the criteria of inclusion of "Cancer patient"

Exclusion

  • For "Cancer patient" :
  • Genetic predisposition already identified at the child
  • Absence of histological confirmation
  • Child died without DNA of the available germinal lineage
  • For "Parent of cancer patient" :
  • Parent whose child doesn't meets the criteria of inclusion of "Cancer patient"

Key Trial Info

Start Date :

November 13 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 22 2024

Estimated Enrollment :

169 Patients enrolled

Trial Details

Trial ID

NCT03472807

Start Date

November 13 2019

End Date

February 22 2024

Last Update

March 17 2025

Active Locations (27)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (27 locations)

1

University Hospital of Amiens

Amiens, France

2

University Hospital of Angers

Angers, France

3

Cancer Center Bergonie Institut

Bordeaux, France

4

University Hospital of Bordeaux

Bordeaux, France

EXOme Rare Cancers in Children (EXOCARE) | DecenTrialz